Capítulo 1851: Chapter 1294: Miraculous Power
After Li Gaoyang was discharged, he did not leave China. He worried that if his illness changed after returning to the United States, he would not receive tily treatnt. His accompanying team rented an entire floor of a hotel near Sanbo Hospital as his temporary residence.
Huang Jiacai was reviewing the training plans of European partners at three in the morning when he received a call from an encrypted international number.
“Mr. Huang, this is Jas Walker.” The voice on the other end had the steady tone unique to the East Coast elite of the United States, “I apologize for disturbing you so late at night. But my father’s situation may not wait for the regular approval process to conclude.”
Huang Jiacai quickly searched his mory for the na, Jas Walker, the son of the Chairman of the Appropriations Committee of the US Senate. His father, Old Senator Walker, had been briefly in the news three months ago for being admitted for treatnt of glioblastoma and then disappeared from public view.
“Mr. Walker, I understand how you feel, but the FDA’s approval process…”
“We are pushing, using every possible thod.” Jas interrupted anxiously, with a slight tremor in his voice, “But the bureaucratic machine cannot keep up with the speed of the tumor’s growth. My father’s primary doctor told us yesterday that only K Therapy can save him now, and if effective treatnt cannot begin within two weeks, he might…”
The phone was silent for a few seconds, then Jas continued, “We have reviewed all of Mr. Li Gaoyang’s treatnt records, and hired three independent dical teams to evaluate. The conclusion is unanimous—K Therapy is his only chance, Mr. Huang, we need your help.”
Huang Jiacai sat up straight, “Mr. Walker, Ruixing is willing to help any patient, but it must comply with dical norms and legal regulations. If the FDA has not approved, we cannot accept clinical test volunteers from abroad.”
“What if I can get FDA approval within seven days?”
This made Huang Jiacai stunned.
“My father has been working in Washington for forty years.” Jas’s tone beca firm, “He has helped many people, and now these people are willing to help him. The FDA director was his classmate in law school, the NIH director was nominated by him, and the Secretary of Health and Human Services worked under him for ten years. If that’s not enough, I have twenty-seven Senate colleagues whose families or constituents are facing the sa desperate situation.”
“I need to discuss dical feasibility with Professor Yang Ping.” Huang Jiacai finally said.
“Of course, we already have a private jet on standby, and the dical team can bring my father and all dical records to China at any ti. If Professor Yang finds it feasible, we will initiate the special approval procedure within twenty-four hours.”
After hanging up the phone, Huang Jiacai sat in his office, unable to calm down for a long ti.
A force he never anticipated was gathering in the United States, driven not by comrcial interests or political calculations but by the most primitive of human emotions: to save the lives of loved ones.
He had originally designed a comprehensive strategy to negotiate with the FDA, involving data sharing, phased approvals, limited pilot programs… He was prepared to spend months or even years to open the US market. But now, an entirely unexpected force had erged, potentially pushing open that heavy door at an incredible speed.
…
Almost simultaneously, Song Zimo received a transatlantic video request. The caller was the vice president of the Royal College of dicine, UK, but he opened with a personal request.
“Dr. Song, I am contacting you on behalf of a family who wishes to remain anonymous. The patient is a mber of a very prestigious family in the UK, diagnosed with a grade IV brainstem glioma.”
Song Zimo frowned, “Our clinical trials in the UK have not yet received approval.”
“This is a special case,” the vice president lowered his voice, “The patient is the sole heir of the family. If… sothing happens, it will not only affect the family but also the foundation, charity organizations, and the network of relationships controlling half of the London Financial City.”
“So?”
“So they are willing to use all resources to urge the British and European Pharmaceutical Agencies to expedite approvals. In fact, they have already done so. Yesterday, the Health Ministers of the UK, Germany, and France had an ergency call. This morning, the EMA held a special eting.”
Song Zimo was shocked, “But hasn’t the EMA just passed the data safety frawork? Regular approvals will take at least six more months…”
“It’s possible to accelerate in special circumstances,” the vice president said, “‘Compassionate use’ clauses can bypass part of the process, as long as the treating party—in this case, you—agrees to accept the patient and provide a comprehensive safety monitoring plan.”
“We need the patient’s complete dical records to evaluate.”
“All materials can be sent to you at any ti, and a private jet is already on standby at Heathrow Airport. The patient will depart imdiately upon approval.”
After the video ended, Song Zimo imdiately found Yang Ping.
The two reviewed so of the dical records that had just been transmitted; the condition was indeed critical, with the tumor’s position tricky and traditional thods exhausted.
“Can it be done?” Song Zimo asked.
Yang Ping studied the images carefully, “The type of tumor fits within our K Therapy’s indicated range, but it’s too large and too deep. The success rate will be reduced, around 70%.”
“But if untreated, death is 100%.” Song Zimo thought, 70% was already very high; he wondered what concept the success rate represented in the professor’s mind.
Yang Ping nodded, “Technically, we can attempt it, but we need to be clear: we must follow formal approval channels; the treatnt risks must be clearly communicated.”
User Comments
0 comments from readers